An Open-label Extension Study of PSMA ADC 2301 in mCRPC

NCT02020135 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
9
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Progenics Pharmaceuticals, Inc.